2010
DOI: 10.1111/j.1399-3089.2010.00587.x
|View full text |Cite
|
Sign up to set email alerts
|

First experience with heterotopic thoracic pig-to-baboon cardiac xenotransplantation

Abstract: This is the first description of a heterotopic thoracic pig-to-baboon heart transplantation. The procedure combines the advantages of a working heart model with the safety of heterotopic transplantation. In contrast to orthotopic transplantation, the recipient heart can assist the donor heart during episodes of rejection. We believe that the heterotopic thoracic model may accelerate the progress into the clinical application of cardiac xenotransplantation. However, successful combination of this heterotopic tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
35
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(36 citation statements)
references
References 9 publications
1
35
0
Order By: Relevance
“…Numerous other pig-to-nonhuman-primate transplantations have been performed, and no transmission of PERV was observed (Table 8). In addition, in heterotopic thoracic pigto-baboon cardiac xenotransplantation (15), no PERV transmission was observed using a Western blot assay to detect PERVspecific antibodies (Denner et al, unpublished data).…”
Section: Pervsmentioning
confidence: 99%
“…Numerous other pig-to-nonhuman-primate transplantations have been performed, and no transmission of PERV was observed (Table 8). In addition, in heterotopic thoracic pigto-baboon cardiac xenotransplantation (15), no PERV transmission was observed using a Western blot assay to detect PERVspecific antibodies (Denner et al, unpublished data).…”
Section: Pervsmentioning
confidence: 99%
“…As xenogeneic transplantation could potentially solve the organ shortage in cardiac transplantation, special interest lies in overcoming the mechanisms of xenograft rejection [2,3]. Several innovations, like genetically modified donor animals [14], achieved increased long-term survival in preclinical xenotransplantation models [15,16,17]. Yet, cardiac xenotransplantation is still far from being established clinically [18].…”
Section: Discussionmentioning
confidence: 99%
“…The group from Munich, Germany, has achieved so far 50 days of survival in a genetically modified animal model with the unique thoracic heterotopic heart transplantation technique developed by Barnard and Losman [33,34], using a dedicated immunosuppressive treatment described above [29 & ]. Before the step into the clinic can be made, the guidelines of the Xenotransplantation ISHLT Advisory Board [35] need to be followed achieving good graft function for a minimum of 3 months in a lifesupporting position in at least 60% of consecutive experiments.…”
Section: Xenotransplantationmentioning
confidence: 99%